Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Beal

Showing results (41-50 of 332) with videos related to

Pageof 34
Sort By:
Molecular Aspects of Medicine|January 1, 1997
Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseasesM F Beal, R T Matthews
Brain Research|May 8, 1989
Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseasesR A Clevens, M F Beal
Annals of the New York Academy of Sciences|May 11, 1992
Huntington's disease and neurotoxinsJ B Martin, M F Beal
Neuroscience Letters|February 24, 1984
The effect of somatostatin on striatal catecholaminesM F Beal, J B Martin
Brain Research|August 13, 1984
Depletion of striatal somatostatin by local cysteamine injectionM F Beal, J B Martin
Annals of Neurology|February 1, 1988
Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's diseaseN W Kowall, M F Beal
Brain Research|January 20, 1987
Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomesG K Chattha, M F Beal
Annals of Neurology|May 19, 2001
Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disordersM A Tarnopolsky, M F Beal
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
CSF neurotransmitter markers in Alzheimer's diseaseM F Beal, J H Growdon
Annals of Neurology|November 1, 1986
Neuropeptides in neurological diseaseM F Beal, J B Martin
Pageof 34

Showing results (41-50 of 332) with videos related to

Sort By:
Pageof 34
Molecular Aspects of Medicine|January 1, 1997
Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseasesM F Beal, R T Matthews
Brain Research|May 8, 1989
Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseasesR A Clevens, M F Beal
Annals of the New York Academy of Sciences|May 11, 1992
Huntington's disease and neurotoxinsJ B Martin, M F Beal
Neuroscience Letters|February 24, 1984
The effect of somatostatin on striatal catecholaminesM F Beal, J B Martin
Brain Research|August 13, 1984
Depletion of striatal somatostatin by local cysteamine injectionM F Beal, J B Martin
Annals of Neurology|February 1, 1988
Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's diseaseN W Kowall, M F Beal
Brain Research|January 20, 1987
Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomesG K Chattha, M F Beal
Annals of Neurology|May 19, 2001
Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disordersM A Tarnopolsky, M F Beal
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
CSF neurotransmitter markers in Alzheimer's diseaseM F Beal, J H Growdon
Annals of Neurology|November 1, 1986
Neuropeptides in neurological diseaseM F Beal, J B Martin
Pageof 34